Lipocine (NASDAQ:LPCN) Lowered to “Hold” at StockNews.com

Lipocine (NASDAQ:LPCN – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Saturday. Lipocine Price Performance Shares of Lipocine stock opened at $3.70 on Friday. The business has a 50-day simple moving average of $6.61 and a 200 day simple moving average […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Upgrades Assurant (NYSE:AIZ) to Buy
Next post Dada Nexus (DADA) Scheduled to Post Earnings on Tuesday